HIGHLIGHTS
- who: BioMed Central et al. from the Address: Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent University, ABaertsoenkaai, Gent, Belgium have published the paper: Bio Med Central, in the Journal: (JOURNAL)
- what: The authors investigated twelve new NM mutants using similar approaches.
- how: The authors conducted the same biochemical experiments for twelve new actin mutants associated with nemaline myopathy.
SUMMARY
Nemaline myopathy (NM) is a neuromuscular disorder, characterized by muscle weakness and hypotonia. Given that αactin is an essential protein for muscle function it is not surprising . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.